ArticleIndian journal of sexually transmitted diseases and AIDS
HIV testing and diagnosis in 2021 at the apex tertiary referral hospital of India: Impact of COVID-19 pandemic continued.
Article in Indian journal of sexually transmitted diseases and AIDS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Timely HIV testing and diagnosis is critically important to achieve an AIDS free world. We previously reported a severe disruption in HIV testing and diagnosis during 2020 due to COVID-19 pandemic. The objective of this study was to assess the impact of COVID-19 pandemic on HIV testing and diagnosis during 2021. Materials and Methods: The documents/records on HIV testing and diagnosis during 2021 were evaluated. Data was analyzed on Microsoft excel and Graph Pad prism v6 software. Results: During 2021, we observed only 3% rise in the number of people tested for HIV compared to 2020. The number of people tested for HIV during 2021 was 55.6% lower than the average number during 2016-2019. Compared to 2020, the number of people tested during 2021 under Client-initiated testing increased by 26.9% but under provider-initiated HIV testing further declined by 15.7%. There was 43.7% decline in the number of individuals diagnosed as HIV positive during 2021 compared to the average number during 2016-2019 due to low HIV testing. HIV testing in 15-34 year-old people (which included young adults) was significantly decreased; HIV testing in other age groups was non-significantly affected. There was 30.9% increase in number of males diagnosed as HIV positive despite <1% change in male HIV testing during 2021 compared to 2020. Conclusion: COVID-19 pandemic during 2020 and 2021 severely disrupted HIV testing and diagnosis. This disruption may fuel HIV transmission and thereby AIDS cases in the coming decade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.